Evidence map›Paper›PMID 26073944›Full record

ArticleCell2015

Enhancing Hematopoietic Stem Cell Transplantation Efficacy by Mitigating Oxygen Shock.

Charlie R Mantel, Heather A O'Leary, Brahmananda R Chitteti, XinXin Huang, Scott Cooper, Giao Hangoc, Nickolay Brustovetsky, Edward F Srour, Man Ryul Lee, Steven Messina-Graham and 9 more

Open access · greenAbstract read
In one paragraph

Article in Cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 197 papers.

0numbers the graph read from it
0cells of the map it votes in
197citing papers in PubMed
21.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

197 citing papers in PubMed, 330 citations in OpenAlex.

  1. Loss of TCA cycle turning promotes stem cell function.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Stem cell functionbioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Microvesicles secreted by CoClAnnals of hematology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Hematopoietic stem cell metabolism within the bone marrow niche - insights and opportunities.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review

137 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Charlie R MantelDepartment of Microbiology/Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Heather A O'LearyDepartment of Microbiology/Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Brahmananda R ChittetiDepartment of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis, IN 46202, USA.
XinXin HuangDepartment of Microbiology/Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Scott CooperDepartment of Microbiology/Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Giao HangocDepartment of Microbiology/Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Nickolay BrustovetskyDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Edward F SrourDepartment of Microbiology/Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis, IN 46202, USA; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Man Ryul LeeDepartment of Microbiology/Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Soonchunhyang Institute of Medi-bio Science, Chungcheongnam-do 336-745, Korea.
Steven Messina-GrahamDepartment of Microbiology/Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
David M HaasDivision of Clinical Pharmacology, Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Nadia FalahDivision of Clinical Pharmacology, Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Reuben KapurDepartment of Microbiology/Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Department of Biochemistry/Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Louis M PelusDepartment of Microbiology/Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Nabeel BardeesyMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
Julien FitamantMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
Mircea IvanDepartment of Microbiology/Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Kye-Seong KimGraduate School of Biomedical Science and Engineering, Hanyang University, Seoul 133-791, Korea.
Hal E BroxmeyerDepartment of Microbiology/Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Electronic address: hbroxmey@iupui.edu.
Indiana University School of MedicineIndiana University – Purdue University Indianapolis · USMassachusetts General Hospital · USHanyang University · KR

Funding

Tumor Microenvironment and Metastasis ProgramP30CA082709 · NCI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Jun Wan · 1999 to 2026
$59.3M
Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Project-005U54DK106846 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Reuben Kapur, Karen Elizabeth Pollok · 2015 to 2026
$9.7M
REGULATION OF HEMATOPOIETIC CELL PRODUCTIONT32DK007519 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI KAPLAN, MARK H · 1986 to 2020
$7.1M
MECHANISMS OF SYNERGISTIC REGULATION OF STEM/PROGENITORSR01HL056416 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI BROXMEYER, HAL E. · 1996 to 2017
$6.0M
Cytokine Enhancement of Myeloid Progenitor Cell SurvivalR01HL067384 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI BROXMEYER, HAL E. · 2001 to 2014
$4.6M
Regulating hematopoietic stem cells and hematopoiesis for clinical efficacyP30DK090948 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI BROXMEYER, HAL E., SROUR, EDWARD F · 2010 to 2014
$3.7M
Enhancing Engraftment of Cord Blood by CD26 InhibitionR01HL112669 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI BROXMEYER, HAL E., FARAG, SHERIF S · 2012 to 2016
$3.6M
Role of p21 activated kinase in LeukemogenesisR01CA173852 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI KAPUR, REUBEN · 2014 to 2025
$3.4M
Role of Shp2 in FLT3-ITD-Induced LeukemogenesisR01CA134777 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI KAPUR, REUBEN · 2011 to 2023
$3.4M
Novel Mechanisms of C-Kit Regulation in Mast CellsR01HL077177 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI KAPUR, REUBEN · 2006 to 2016
$3.0M
NCATS NIH HHS UL1 TR001108NCI NIH HHS P30 CA082709NCI NIH HHS R01 CA134777NCI NIH HHS R01 CA173852NHLBI NIH HHS R01 HL056416NHLBI NIH HHS R01 HL067384NHLBI NIH HHS R01 HL077177NHLBI NIH HHS R01 HL112669NHLBI NIH HHS R01 HL67384NIDDK NIH HHS DK07519NIDDK NIH HHS P30 DK090948NIDDK NIH HHS T32 DK007519NIDDK NIH HHS U54 DK106846NINDS NIH HHS R01 NS078008
6 · The paper itself

Abstract

Hematopoietic stem cells (HSCs) reside in hypoxic niches within bone marrow and cord blood. Yet, essentially all HSC studies have been performed with cells isolated and processed in non-physiologic ambient air. By collecting and manipulating bone marrow and cord blood in native conditions of hypoxia, we demonstrate that brief exposure to ambient oxygen decreases recovery of long-term repopulating HSCs and increases progenitor cells, a phenomenon we term extraphysiologic oxygen shock/stress (EPHOSS). Thus, true numbers of HSCs in the bone marrow and cord blood are routinely underestimated. We linked ROS production and induction of the mitochondrial permeability transition pore (MPTP) via cyclophilin D and p53 as mechanisms of EPHOSS. The MPTP inhibitor cyclosporin A protects mouse bone marrow and human cord blood HSCs from EPHOSS during collection in air, resulting in increased recovery of transplantable HSCs. Mitigating EPHOSS during cell collection and processing by pharmacological means may be clinically advantageous for transplantation.

Indexed as

Bone Marrow1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAnimalsCyclophilinsFemaleFetal BloodHematopoietic Stem CellsHematopoietic Stem Cell TransplantationHumansHypoxiaMiceMice, Inbred C57BLOxygenPeptidyl-Prolyl Isomerase FTumor Suppressor Protein p531-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineCyclophilinsOxygenPeptidyl-Prolyl Isomerase FPPIF protein, mouseTumor Suppressor Protein p53

Identifiers

PMID26073944
PMCPMC4480616
OpenAlexW1834094542

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.